Stay updated on Talazoparib in DNA Repair Defects Clinical Trial
Sign up to get notified when there's something new on the Talazoparib in DNA Repair Defects Clinical Trial page.

Latest updates to the Talazoparib in DNA Repair Defects Clinical Trial page
- Check2 days agoChange DetectedA new page revision label, Revision: v3.7.0, was added, replacing the previous Revision: v3.6.6. This signals an update to the page version rather than changes to the study details.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedAdded the Revision: v3.6.6 tag. Removed Prostate cancer, related topics:, MedlinePlus Genetics, and Revision: v3.6.5 from the related topics area.SummaryDifference0.1%

- Check23 days agoChange DetectedAdded related topic references and a grant/contract note to the study page, indicating indexing and topic associations rather than changes to trial design or eligibility. The additions include a 2016 NIH grant/contract line, and references to Prostate Cancer and MedlinePlus Genetics.SummaryDifference0.1%

- Check30 days agoChange DetectedThe page’s related topics section no longer includes Prostate cancer and MedlinePlus Genetics, removing those cross-reference links from the study record.SummaryDifference0.1%

- Check37 days agoChange DetectedDifference0.1%

- Check52 days agoChange DetectedThe page shows Revision: v3.6.4, replacing the previous Revision: v3.6.3. This signals a small update to the page's version history rather than changes to the study details.SummaryDifference0.0%

Stay in the know with updates to Talazoparib in DNA Repair Defects Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Talazoparib in DNA Repair Defects Clinical Trial page.